Unlock actionable insights in your biological data by streamlining your data interpretation with IPA Interpret. The newest feature of your trusted pathway analysis software, QIAGEN IPA, includes: Content powered by IPA's extensive, manually curated knowledge base and aided by AI Easy-to-share reports and updated visualizations to facilitate collaboration and dissemination of research findings Easy access […]
Meet OmicSoft Explorer, a new feature included with your QIAGEN IPA/OmicSoft subscriptions. See how you can find ‘omics datasets to inform your next experiments or support your grant proposals. With OmicSoft Explorer, you can: Search over 10,000 disease-relevant datasets for clinical, in vitro, normal tissue and more Reveal top differentially expressed genes from over 200,000 […]
Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA. You’ll learn to: Upload multiple dataset types (e.g., RNA-seq, proteomics, metabolomics) and perform interactive core/pathway analysis in IPA Learn how to interpret […]
Join us for a 90-minute LIVE group session designed to address different technical questions regarding IPA certification. QIAGEN IPA scientists will answer different IPA related technical questions and clarify various […]
This training will be relevant to both QIAGEN Main and Genomics workbench users and prospects who are interested in below analytics. Alignment and tree construction Sanger sequencing analysis Cloning and […]
While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data sources such as The Cancer Genome Atlas (TCGA), such investigation is […]
In this training, you will learn how to analyze and interpret your own single cell RNA-seq data using QIAGEN CLC Genomics Workbench starting with either FASTQ or matrix files. Using […]
In the drug discovery pipeline, evaluating multiple pathways between a drug target and disease is crucial for identifying potential therapeutic approaches. By examining overlapping pathways between competing drugs, researchers can […]
Disease pathogenesis is often context-dependent, specifically on tissue expression profiles within a given disease context. However, tissue expression profile of drug targets or potential targets is often difficult to ascertain. […]
This is the description that will appear on the webinar page. I want to ensure that it is long enough to show really what happens when we put some really very long text in here for testing. There could be an entire article. Oh and maybe we add new line break?
There were 2 just there. Maybe those change things? Lets get this out and tested.
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis […]
Watch NowIn this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an […]
Watch NowMore and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and […]
Watch NowThere is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This […]
Watch NowYou’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for […]
Watch NowIngenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships […]
Watch Now
